Lisata Therapeutics Inc (LSTA)
2.77
-0.04
(-1.60%)
USD |
NASDAQ |
May 17, 16:00
2.76
-0.01
(-0.36%)
After-Hours: 20:00
Lisata Therapeutics Shareholders Equity (Quarterly): 43.00M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 43.00M |
December 31, 2023 | 48.15M |
September 30, 2023 | 52.96M |
June 30, 2023 | 57.97M |
March 31, 2023 | 60.96M |
December 31, 2022 | 66.58M |
September 30, 2022 | 72.02M |
June 30, 2022 | 82.39M |
March 31, 2022 | 88.50M |
December 31, 2021 | 92.25M |
September 30, 2021 | 98.67M |
June 30, 2021 | 104.93M |
March 31, 2021 | 110.27M |
December 31, 2020 | 32.50M |
September 30, 2020 | 37.74M |
June 30, 2020 | 33.81M |
March 31, 2020 | 17.24M |
December 31, 2019 | 20.82M |
September 30, 2019 | 25.25M |
June 30, 2019 | 29.89M |
March 31, 2019 | 34.73M |
December 31, 2018 | 37.73M |
September 30, 2018 | 41.08M |
June 30, 2018 | 43.74M |
March 31, 2018 | 45.59M |
Date | Value |
---|---|
December 31, 2017 | 50.51M |
September 30, 2017 | 53.33M |
June 30, 2017 | 54.42M |
March 31, 2017 | -0.791M |
December 31, 2016 | 4.884M |
September 30, 2016 | 10.75M |
June 30, 2016 | 6.050M |
March 31, 2016 | 13.66M |
December 31, 2015 | 23.71M |
September 30, 2015 | 55.43M |
June 30, 2015 | 66.38M |
March 31, 2015 | 50.40M |
December 31, 2014 | 58.51M |
September 30, 2014 | 63.00M |
June 30, 2014 | 78.04M |
March 31, 2014 | 59.64M |
December 31, 2013 | 62.54M |
September 30, 2013 | 35.70M |
June 30, 2013 | 33.46M |
March 31, 2013 | 29.42M |
December 31, 2012 | 33.18M |
September 30, 2012 | 48.21M |
June 30, 2012 | 46.35M |
March 31, 2012 | 63.37M |
December 31, 2011 | 62.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
17.24M
Minimum
Mar 2020
110.27M
Maximum
Mar 2021
58.79M
Average
55.46M
Median
Shareholders Equity (Quarterly) Benchmarks
Becton Dickinson & Co | 25.65B |
Edwards Lifesciences Corp | 7.118B |
AIM ImmunoTech Inc | 10.23M |
Protalix BioTherapeutics Inc | 29.79M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 48.24M |
Total Liabilities (Quarterly) | 5.497M |